Two Indian Generic Firms Drive 4% Of Industry Sales Growth
This article was originally published in PharmAsia News
Executive Summary
India makers of generic drugs are driving a large increase in the growth of the nation’s pharmaceutical exports, primarily by a one-each version of Pfizer and Eli Lilly drugs.